FDA Clears Orchestra BioMed's Virtue SAB Trial To Treat Coronary ISR
29/4 19:09
(RTTNews) - Orchestra BioMed Holdings, Inc. (OBIO), a biomedical company focused on advancing high-impact technologies, announced that the U.S. Food and Drug Administration or FDA has approved an Investigational Device Exemption or IDE amendment for its Virtue SAB in the Treatmen...